You may search any word / name within the scientific programme by simply writing it in the above search box and clicking ‘Enter’. Please note that when you make a search, the results are coming under each day and each hall separately. Therefore, please make sure to look into different days & halls when you are making a search.
AEPC 2023 SCIENTIFIC PROGRAMME OVERVIEW
Please click on the image below to view it larger or click here to view the programme at a glance as a PDF file.
Please click here to view the detailed scientific programme in PDF.
| WG Sessions | Abstract Sessions | Nursing Sessions |
| Moderated Posters | Plenary & Keynote Lectures | Business Meetings |
| Industry Sessions | ||
| 16:00 - 17:30 | OPENING CEREMONY & MANNHEIMER LECTURE Speaker: Daniel J. Penny, USA |
| 17:30 - 19:00 | WELCOME RECEPTION |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 11:00 | AEPC BUSINESS MEETING |
| 11:00 - 11:30 | BREAK |
| 11:30 - 13:00 | Hot Topics in Congenital Cardiology Separate / WG: Cardiac Imaging Chair: Gerald Greil, USA Co- chair: Andrew Redington, USA Co-chair: Jeffrey Jacobs, USA Every patient should have MR lymphangiography as part of pre Fontan assessment? Pro / Con, Yoav Dori & Vibeke Hjortdal Fenestrations which remain open should be left open to preserve longterm liver function or must everyone be closed? Pro/Con, Kevin Walsh & Marc Gewillig Every single ventricle patient (Fontan) should have annual serial liver imaging + biopsy from 10 years of age? Pro/Con, Jan Hinnerk Hansen & Emer Fitzpatrick |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 13:20 - 14:20 | Industry Symposium |
| 14:30 - 16:00 | Congenitally corrected transposition - from fetal life to adulthood Joint / WG: Cardiac Imaging & Adult Congenital Heart Disease Chair: Inga Voges, Germany Co- chair: Werner Budts, Belgium Co-chair: Krishna Kumar, India Embryology and morphology of CCTGA, Robert Anderson, UK How to image patients with CCTGA - multimodality or single imaging modality best?, Giovanni DiSalvo, Italy Childhood management - double switch or not worth the hassle?, David Barron, Canada Adult management- when to intervene on the tricuspid valve and how?, Alessandro Giamberti, Italy |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | Cardiovascular risk management in the childhood obesity epidemic - what can the pediatric cardiologist do? Separate / WG: Sports cardiology, physical activity and prevention Chair: Annette Wacker Gussmann, Germany Co- chair: Felicia Nordenstam, Sweden Obesity and physical activity in patients with congenital heart disease - role of prevention in clinical pediatric cardiology practice, Constance Weismann, Germany Arterial characteristics and cardiovascular risk factors in obese children and adolsecents, Henk Schipper, The Netherlands Inpatient vs outpatient rehabilitation programs for pediatric obesity, Nicola Stöcker, Germany What can we learn from adults: cardiovascular risk profile following successful weight loss, Donal O’Shea, Ireland Healthy families in healthy cities- cardiovascular risk prevention in urban areas, Peter Fritsch, Austria |
| 20:00 | JUNIOR MEMBERS' PARTY & NURSES & ALLIED HEALTH PROFESSIONALS RECEPTION (optional, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 11:00 - 11:30 | BREAK |
| 11:30 - 13:00 | Virtual/Augmented Reality and simulation in CHD Separate / WG: Interventional Cardiology Chair: Gianfranco Butera, Italy Co- chair: Regina Bökenkamp, The Netherlands Virtual reality and engineering simulations for nulls – An engineer talk to make it easy, Silvia Schievano, UK Virtual reality/simulation for training and counseling, Massimo Chessa, Italy How simulation and virtual reality helps real surgeons, Martin Kostolny, UK Simulating virtually a successful cath procedure, Phuoc Duong, UK Cardiovascular simulation as a decision support tool, Francesca Raimondi, Italy |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 14:30 - 16:00 | Fontan: A Necessary Evil? Seperate / WG: Congenital Heart Surgery Chair: Hitendu Dave, Switzerland Co- chair: Rodney Franklin, UK Fontan Candidate: What to look for?, Brian McCrossan, Northern Ireland A good Fontan: Surgical Aspects, Jonathan McGuinness, Ireland Optimizing Fontan: Catheter Intervention, Marc Gewillig, Belgium Multimodality imaging Fontan circulation (incl 4D flow), Arno Roest, The Netherlands The Failing Fontan, Sachin Khambadkone, UK |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | Complete AVSD: The Monster in the room Joint / WG: Congenital Heart Surgery & EACTS Chair: Mark Hazekamp, Netherlands Co- chair: Louise Morrison, Northern Ireland Complete AVSD: Diagnosis & Management before complete repair, Andrew Sands, Northern Ireland Balanced Complete AVSD: Surgical Techniques, Lars Nolke, Ireland Residual Lesions: Indications for Intervention, Adam James, Ireland Reoperation after Complete AVSD repair, Conal Austin, UK |
| 20:00 | JUNIOR MEMBERS' PARTY & NURSES & ALLIED HEALTH PROFESSIONALS RECEPTION (optional, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 11:00 - 11:30 | BREAK |
| 11:30 - 13:00 | Complex TGA with LVOTO Joint / WG: Cardiovascular Morphology & Surgery, Imaging, ACHD Chair: Monique Jongbloed, Netherlands Co- chair: TBA Anatomy of TGA with LVOTO, Annalisa Angelini, Italy Imaging of TGA with LVOTO, Heynric Grotenhuis, Netherlands Prenatal assessment of systemic right ventricle, Sally-Ann Clur, Netherlands Surgery of TGA with LVOTO, Hitendu Dave, Switzerland ACHD of TGA with LVOTO, Jaspal Dua, UK |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 14:30 - 16:00 |
JSPCCS-AEPC Joint Session (Japanese) |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | Transcatherer Ablation in Children with and without CHD: What’s new? Separate / WG: Cardiac dysrhythmias and electrophysiology Chair: Jan Janousek, Czech Republic Co-chair: Fabrizio Drago, Italy Co-chair: Jeffrey J Kim, USA New ablation strategies to reduce catheters and fluoroscopy, Thomas Kriebel, Germany What energy, now and in the future, in the different substrates : RF, PFA, HPSD, Cryo, Laser?, Maria Miszczak-Knecht, Poland Complex Arrhythmia Mapping in CHD : CT / CMR merge, ICE, HD mapping... what do we need to increase success rate?, Edward Walsh, USA Difficult ablations in the structurally normal heart: how to ablate complex and unusual APs and difficult AVNRT, Jeffrey J Kim, USA Complex ablations in palliated CHD with in inaccessible heart chambers:how do we get there and what should we do?, Roman Gebauer, Germany |
| 20:00 | JUNIOR MEMBERS' PARTY & NURSES & ALLIED HEALTH PROFESSIONALS RECEPTION (optional, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 11:00 - 11:30 | BREAK |
| 11:30 - 13:00 | Genetic testing and implications for diagnosis and therapy? Separate / WG: Genetics, Basic Science, Myocardial Disease Chair: Sabine Klaassen, Germany Co- chair: Michael Ackerman, USA Co-chair: Silvia Alverez, Portugal Marfan syndrome, Laura Muino Mosquera, Belgium Arrhythmogenic cardiomyopathy (ACM), Juan Kaski, UK Congenital heart defects, Terence Prendiville, Ireland Cardiac channelopathies, Michael Ackerman, USA |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 14:30 - 16:00 | Heart Failure Management through the cycle of life from fetal to ACHD Separate / WG: Pulmonary hypertension, heart failure and transplantation Chair: Joseph Rossano, USA Co- chair: Julie Wacker, Switzerland Bespoke Treatment Strategies for Prenatal and Infant Heart Failure, Dietmar Schranz, Germany Heart Failure in Paediatric population, Is management different in failing SV and DCM, Damien Bonnet, France Management of HFpEF, Milind Chaudhari, UK Heart Failure in ACHD population, Alexander Van De Bruaene, Belgium |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | MP01 Chairs: Heynric Grotenhuis & TBA P-096 3D MRA with image-based navigation for highly-efficient imaging in patients with Congenital Heart Disease- Single center study, Anastasia Fotaki, UK P-099 Hypoplastic left heart syndrome has asymmetric leaflet expansion and increased tenting volume of the tricuspid valve: A prospective 3DE study, Martha Maria Moran, Canada P-118 The neonatal QRS complex and its association with left ventricular mass, Julie Molin, Denmark P-125 The prognostic role of systolic longitudinal strain in congenital heart disease with systemic right ventricle: a systematic review and meta-analysis, Dan M. Dorobantu, UK P-147 Newly High-Frame Rate Blood Speckle Tracking Echocardiography For New Insights of Aortic Flow Pattern in Children, Massimiliano Cantinotti, Italy P-165 Hemodynamics in children with partial anomalous pulmonary venous return and atrial septal defect using 4D-flow MRI, Fraser Maurice Callaghan, Switzerland P-167 Intracavitary blood flow dynamics in the systemic right ventricle: a 4D-Flow MRI study, Giulia Pasqualin, Italy P-171 Association Between Arterial Stiffness of the Common Carotid Artery and Left Ventricular Function in Children, Adolescents and Young Adults, Franziska Sciuk, Germany P-172 Regional Elevation of Liver T1 in Fontan-Associated Liver Disease, Edythe Tham, Canada P-176 Early left atrial dysfunction by strain echocardiography in Duchenne Muscular dystrophy, Jarosław Meyer Szary, Poland P-502 Comparison of hemodynamic parameters and pulmonary artery dimension in single ventricle patients with and without closure of veno-venous collaterals, Alessia Callegari, Switzerland P-518 Interventional Extracardiac Fontan – Technique, feasibility, immediate results and short term follow up - a case series, Prakash Ramachandra, India P-462 Multicenter experience with Optimus balloon-expandable cobalt-chromium stents in congenital heart disease interventions, Raymond N. Haddad, France P-478 Transcatheter pulmonary valve replacement after RVOT reconstruction with a composite porcine valved conduit of bovine pericardium, Jan Hinnerk Hansen, Germany P-508 Results of perventricular device closure of ventricular septal defects in children without cardiopulmonary bypass., Shravan Kanaparthi, India |
| 20:00 | JUNIOR MEMBERS' PARTY & NURSES & ALLIED HEALTH PROFESSIONALS RECEPTION (optional, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 11:00 - 11:30 | BREAK |
| 11:30 - 13:00 | Cardio-Oncology Separate / WG: Sports Cardiology, Physical Activity and Prevention Chair: Sabine Kesting, Germany Co- chair: Jochen Weil, Germany Cardiovascular risk factors in childhood cancer survivors, Vesna Herceg- Cavrak, Croatia German Recommendations of pediatric cardio- oncology, Jochen Weil, Germany Physical activity interventions in pediatric cardio-oncology, Sabine Kesting, Germany Role of exercise stress echocardiography in the follow-up of hematological patients with history of cardiac dysfunction, Ugo Giordano, Italy |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 13:20 - 14:20 | Junior Interventionalists Meet Seniors |
| 14:30 - 16:00 | Morphological Session: Fontan hearts Separate / WG: Cardiovascular Morphology Chair: Adam Kolesnik, Poland Co- chair: Matthias Sigler, Germany History and types of Fontan operation, Vladimiro Vida, Italy Hearts and organs after Fontan completion, Monique Jongbloed, Netherlands Hearts and organs after Fontan completion, Annalisa Angelini, Italy |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 |
Advanced imaging in fetal CHD- what is new ? |
| 20:00 | JUNIOR MEMBERS' PARTY & NURSES & ALLIED HEALTH PROFESSIONALS RECEPTION (optional, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 11:00 - 11:30 | BREAK |
| 11:30 - 13:00 | AS01 - Cardiac Dysrhythmias and Electrophysiology Chairs: Fabrizio Drago & Mark Walsh O-01 Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis: A Danish pediatric population, Jani Thuraiaiyah, Denmark O-02 Myocardial work in ventricular preexcitation, Tereza Zmatlíková, Czech Republic O-03 Ventricular arrhythmias in primary benign cardiac tumors in children: anatomical and histological predictors in a long term follow up, Silvia Placidi, Italy O-04 The clinical course of asymptomatic children with {RYR2}-mediated catecholaminergic polymorphic ventricular tachycardia, Puck J. Peltenburg, Netherlands O-05 Initial experience of left bundle branch pacing in paediatric patients. The future is here., Ferran Roses Noguer, Spain O-06 Molecular genetic testing in children and adolescents with inherited arrhythmia syndromes – results of the German multicenter COGIA study, Lea Lippert, Germany O-07 3d-electroanatomic mapping-guided conduction system pacing preserves electromechanical function in paediatric patients with atrioventricular block, Massimo Stefano Silvetti, Italy O-08 Initial Data From the International Prospective “Observational Study on Catheter Ablation in Pediatric Patients” (OSCA-PED), Ulrich Krause, Germany |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 13:00 - 14:00 | |
| 14:30 - 16:00 | AS02 - Fetal Cardiology Chairs: Taisto Sarkola & Eva Grohmann O-09 Use of pressure wires during fetal aortic valvuloplasty in fetuses with critical aortic stenosis, Andreas Tulzer, Austria O-10 Haemodynamic effects of acute maternal hyperoxygenation in fetuses with suspected coarctation of the aorta, Milou PM van Poppel, UK O-11 MRI nutmeg lung pattern as the useful diagnostic tool of the restrictive pulmonary venous return in fetuses with various congenital heart defects, Monika Bekiesinska Figatowska, Poland O-12 Prenatal diagnosis, pregnancy and postnatal outcomes in fetuses having redundant foramen ovale flap aneurysm associate with/without heart defects, Balaganesh Karmegaraj, India O-13 Single ventricle journey from fetus to first procedure. A United Kingdom multicentre experience, Peter John Lillitos, UK O-14 Maternal Anti-Ro Antibody Levels are Strongly Associated with the Development of Immune-Mediated Fetal Heart Disease, Edgar Jaeggi, Canada O-15 Prenatal diagnosis, associated findings, and early postnatal outcomes in fetuses with congenitally corrected transposition of the great arteries, Maria Kavga, UK O-16 Early diagnosis of tuberous sclerosis complex is a prenatal diagnosis, Monika Bekiesinska Figatowska, Poland |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | AS04 - Genetics, Basic Science and Myocardial Disease Chairs: Juan Kaski, Sergio Laranjo O-25 Left ventricular non-compaction in childhood: echocardiographic follow-up and prevalence in first-degree relatives, Thilde Olivia Kock, Denmark O-26 Hypoxia-Inducible Factor-1α signaling contributes to disease pathogenesis in sarcomeric hypertrophic cardiomyopathy, Sarala Raj Murthi, Germany O-27 Cardiovascular screening in cutis laxa syndromes, Ilse Meerschaut, Belgium O-28 Natural history and predictors of mortality and arrhythmic events in children with RASopathy-associated hypertrophic cardiomyopathy, Olga Dimitra Boleti, UK O-29 Clinical course of rhabdomyomas in tuberous sclerosis complex – 16-years single centre experience, Ivana Cerovic, Serbia O-30 Impact of genotype on aortic disease progression in patients with Marfan syndrome and Loeys-Dietz syndrome, Aitor Guitarte Vidaurre, France O-31 Childhood-onset lamin A/C cardiomyopathy, Marit Kristine Smedsrud, Norway O-32 Analysis of the mutational spectrum and diagnostic yield in a cohort of patients referred for study of hypertrophic cardiomyopathy, Ivonne Johana Cárdenas Reyes, Spain |
| 20:00 | JUNIOR MEMBERS' PARTY & NURSES & ALLIED HEALTH PROFESSIONALS RECEPTION (optional, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 11:00 - 11:30 | BREAK |
| 11:30 - 13:00 | Knowledge translation/implementation of research in the clinical setting Separate / WG: NURSING AND ALLIED HEALTH PROFESSIONALS Chair: Sofi Andersson Stavridis, Sweden Co- chair: Rebecca Reid, Northern Ireland Implementing new models of care within congenital heart disease – barriers and facilitators, Markus Saarijärvi, Sweden Guidelines within congenital heart disease – are they implemented?, Eva Goossens, Belgium Implementation of Evidence-Informed Family Nursing Practices, Imelda Coyne, Ireland We All Want Progress But Are Resistant to Change, Gil Wernovsky, USA |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 13:00 - 14:00 |
Nurse Symposium by Proveca Chair: Tara Bharucha, UK |
| 14:30 - 16:00 |
AS03 - Nursing & Neurodevelopment and Psychosocial Care Chair: Eva Goossens, Belgium Co-chair: Markus Saarijärvi, Sweden O-17 Impact of Electric seizures and aEEG background pattern during cardiac surgery, Marta Camprubí Camprubí, Spain O-18 My transition, my care: providing individualised congenital heart disease transition care., Danielle Poole, UK O-19 Psychological quality of life in mothers of children with congenital heart disease: A longitudinal study from hospital discharge to adolescence, Melanie Ehrler, Switzerland O-20 Impact of postoperative necrotizing enterocolitis on neurodevelopmental outcome – The Swiss Neurodevelopmental Outcome Registry for Children with CHD, Walter Knirsch, Switzerland O-21 Hippocampal subfield alterations and working memory in children with congenital heart disease, Beatrice Latal, Switzerland O-22 Facilitators and barriers for continued follow-up care after transfer – from a healthcare provider’s perspective, Sandra Skogby, Sweden O-23 Optimizing transfer to adult care for young people with congenital heart disease, Birgitte Lykkeberg, Denmark O-24 Sustained effects of cardiac rehabilitation on the exercise function, quality of life and self-esteem of patients with complex congenital heart diseas, Ana Clara Félix, Portugal |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 |
Educational activity How to write a successful abstract, Imelda Coyne, Ireland |
| 20:00 | JUNIOR MEMBERS' PARTY & NURSES & ALLIED HEALTH PROFESSIONALS RECEPTION (optional, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | Ebstein anomaly - a paradigm shift in management over last decade (In Honour Prof. Marc deLeval) Joint / WG: Cardiac Imaging & Congenital Heart Surgery Chair: David Barron, Canada Co- chair: Jan Marek, UK Co-chair: Marina Hughes, UK Morphological considerations in Ebstein anomaly, Lucile Houyel, France Antenatal and postnatal imaging of the patient with Ebsteins anomaly, Jan Marek, UK Ebstein malformation of the tricuspid valve: watchful waiting is preferred, David Barron, Canada Ebstein malformation of the tricuspid valve: surgical intervention, the sooner the better, Viktor Tsang, UK |
| 10:30 - 11:30 | BREAK |
| 11:00 - 11:30 | HAUSDORF LECTURE Innovations in Pediatric/congenital Interventional Cardiology Keynote: Ziyad Hijazi, Qatar |
| 11:30 - 13:00 | AS05 - Cardiac Imaging Chairs: Francesca Raimondi & Inga Voges O-39 Ventricular Performance in patients with Transposition of the Great Arteries after Arterial Switch Operation at mid-term follow-up Covadonga, Terol Espinosa De Los Monteros, Netherlands O-40 Role of Stress Perfusion in Cardiac Magnetic Resonance Imaging in Paediatric patients, Palak Gupta, UK O-41 More than 25 years experience in diagnosis and treatment of newborns with Pulmonary Atresia with Intact Ventricular Septum, Giulia Tuo, Italy O-42 Ebstein's Valve Rotation Angle: a quantitative index of anatomical severity and clinical risk in Ebstein’s Anomaly, Giulia Pasqualin, Italy O-43 Double aortic arch: a comparison of fetal CMR, postnatal CT and surgical findings, Milou PM van Poppel, UK O-44 Cardiac Magnetic Resonance Imaging 6 months after the onset of PIMS-TS – a retrospective follow-up study, Thomas Karas, Austria O-45 Advanced echocardiographic and CMR features of patients with repaired Tetralogy of Fallot in the long-term follow-up, Anna Gozzi, Italy O-46 Predictive factors of left ventricular dysfunction after pulmonary valve balloon dilation in neonates with critical pulmonary stenosis, Patrizio Moras, Italy |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 13:20 - 14:20 | Industry Symposium |
| 14:30 - 16:00 | Antenatal diagnosis and urgent postnatal interventions Joint / WG: Interventional Cardiology & Fetal cardiology Chair: Gerald Tulzer, Austria Co- chair: Wayne Tworetzky, USA How does the fetal cardiologist judge the urgency of postnatal interventions?, David Lloyd, UK How do we plan an urgent postnatal intervention? How to prepare the patient and the parents?, Ingrid van Beynum, The Netherlands Rapid Cases Pro-con: The sun should not go down over a critical aortic stenosis of the newborn, Eva Grohmann & Thomas Krasemann Differences in management of neonates with or without antenatal diagnosis- my personal experience, Kevin Walsch, Ireland |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | Introduction of cardiac devices Joint / WG: Task Force on Clinical Drug Trials & Interventional Cardiology Chair: Daniel de Wolf, Belgium Co- chair: Regina Bökenkamp, The Netherlands Device approval: how it was and how it should be ideally: interventionalist’s point of view, Shakeel Qureshi, UK Device approval: how it was and how it should be ideally: surgeon’s point of view, Mark Hazekamp, The Netherlands Device approval: how it was and how it should be ideally: manufacturer's point of view, Allen Tower Jr, USA Device approval: how it was and how it should be ideally: regulatory point of view, Tom Melvin, Ireland |
| 20:00 | MEETING NETWORKING DINNER (optional ticket event, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | Sport in Pediatric Patients with Arrhythmia or ECG Anomalies Joint / WG: Cardiac dysrhythmias and electrophysiology & Sports cardiology, physical activity and prevention Chair: Peter Fritsch, Austria Co- chair: Alice Maltret, France The problem of sports eligibility in paediatric patients with arrhythmias: are current guidelines enough to make a decision?, Graham Stuart, UK PVCs in the normal heart: how to evaluate them in order to decide on sport eligibility?, Laszlo Kornyei, Hungary Non-specific repolarization anomalies: what is the correct protocol for sports eligibility?, Ugo Giordano, Italy Channelopathies: do these patients have the opportunity to play competitive sports?, Nico Blom, The Netherlands Helping our athletes reach their goals safely – can we learn something from the FIFA World cup 2022 sports cardiology set up., Guido Pieles, UK |
| 10:30 - 11:30 | BREAK |
| 11:30 - 13:00 |
AS06 - Congenital Heart Surgery Chairs: Hitendu Dave & TBA
|
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 14:30 - 16:00 | Surgical and catheter approach to single ventricle Joint / WG: Adult Congenital Heart Disease & Congenital Heart Surgery Chair: Jaspal Dua, UK Co- chair: Hitendu Dave, UK Co-chair: Phillip Roberts, Ireland Systemic atrio-ventricular valve failure in the univentricle: pro pharmacotherapy, Hannes Sallmon, Germany Systemic atrio-ventricular valve failure in the univentricle: pro surgery, Federica Caldarone, Italy Transcatheter completion of Hraska, Jonathan Rome, USA How close are we to transcatheter completion of Fontan?, Athar Qureshi, USA |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | Heart Transplant and VAD in ACHD- dream versus reality Joint / WG: Pulmonary hypertension, heart failure and transplantation & Adult Congenital Heart Disease & Congenital Heart Surgery Chair: Jaspal Dua, UK Co- chair: Hannes Sallmon, Germany Acute and durable mechanical circulatory support as a salvage in failing circulation in ACHD patient, Fabrizio De- Rita, UK Complex ACHD patients: technical and organizational challenges, Edward Hickey, USA Debate: Heart alone Transplant in Fontan Patient, Lucy Roche, Canada Debate: Heart and Liver Transplant in Fontan patient, Justyna Rybicka, UK |
| 20:00 | MEETING NETWORKING DINNER (optional ticket event, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 |
Young Investigator Award O-33 Human cardiosphere-derived cells with activated mitochondria for better myocardial regenerative therapy, |
| 10:30 - 11:30 | BREAK |
| 11:30 - 13:00 |
AS07 - Interventional Cardiology Chairs: Thomas Krasemann & TBA
|
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 14:30 - 16:00 |
Live Catheterisation Cases |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | Abnormalities of systemic venous return Joint / WG: Cardiovascular Morphology & Imaging, Interventional, Fetal Chair: Grazyna Brzezinska-Rajszys, Poland Co- chair: Anna Seale, UK Development and morphology of abnormal systemic venous return, Adam Kolesnik, Poland Fetal echocardiography of systemic venous return, Orla Franklin, Ireland Imaging of abnormal systemic venous return, Christian Meierhofer, Germany Interventions in abnormalities of systemic venous return, Jamie Bentham, UK |
| 20:00 | MEETING NETWORKING DINNER (optional ticket event, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:30 - 11:00 | PDA closure Separate / WG: Interventional Cardiology Chair: Damien Kenny, Ireland Co- chair: Alban Baruteau, France Premmies- does the ductus really cause problems?, Tim Hundscheid, Netherlands Ex-Premmies – if we have to close the duct later, how does this differ from other children?, Gareth Morgan, USA Different devices for premmies (Piccolo, Micro-plug), Ina Michel-Behnke, Austria The other end of the spectrum- does it make sense to close a duct in geriatrics?, Phillip Roberts, Ireland |
| 11:00 - 11:30 | BREAK |
| 11:30 - 13:00 |
MP02 Chairs: TBA & TBA P-091 Comparing predictive power of PRIMACY, HCMRisk-Kids and ESC HCM risk-calculator in assessing risk for sudden cardiac death, Ingegerd Östman Smith, Sweden P-046 Conduction system pacing guided by 3D mapping in paediatric patients with congenitally corrected transposition of the great arteries, Carla Favoccia, Italy P-074 Neurologic Manifestations in Children with Congenital Arrhythmia Syndromes Subanalysis of the German COGIA Study, Fridrike Stute, Germany P-057 ECG screening: is time to routinely introduce it in apparently healthy schoolchildren?, Stella Maiolo, Italy P-062 Heart and beyond the heart: clinical spectrum of CACNA1C variants, literature revision, Anwar Baban, Italy P-073 “I have a dream”: zero or near-zero X-ray pacemaker implantation in paediatric patients., Massimo Stefano Silvetti, Italy P-076 Surpassing the complex substrate of accessory pathways ablation in Ebstein Anomaly, Sérgio Matoso Laranjo, Portugal P-209 Pre-Glenn lymphatic abnormalities on MRI in single-ventricle congenital heart defects, Rasmus Kristensen, Denmark P-227 Extracorporeal Membrane Oxygenation in Postcardiotomy Pediatric Patients: 18 Years of Experience, Bunty Ramchandani, Spain P-198 Long-term follow-up of atrioventricular valve function in Fontan patients, Thierry Bové, France P-242 Technique of Deferring Decannulation in Pediatric ECMO - 10 years of experience, Inigo Velasco, Spain P-200 Outcomes after Ross procedure with pulmonary autograft reinforcement using reimplantation technique, Lisa Guirgis, France P-250 Management of percutaneous pulmonary valve endocarditis: a multidisciplinary approach, Micol Rebonato, Italy P-260 Probability of Truncal Valve Replacement within 30 years after the correction, Václav Chaloupecký Jr., Czech Republic P-186 Univentricular heart in human heterotaxy syndrome: an anatomic study, Lucile Houyel, France |
| 14:30 - 16:00 | Education in Congenital Heart Disease Separate / WG: Education Committee Chair: Skaiste Sendzikaite, Lithuania Co- chair: Olli Pitkainen, Finland Standardisation and key competencies in training congenital cardiologists, Ornella Milanesi, Italy Training the trainers, Ruth Heying, Belgium Simulation in training of cardiology fellows/trainees, Dimpna Calila Albert Brotons, Saudi Arabia How to write a grant, Inga Voges, Germany How to write a paper, Karolis Azukaitis, Lithuania |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 |
MP04 Chairs: Georgia Sarquella-Brugada & Renate Oberhoffer-Fritz
P-436 Acute myocarditis in children in the SARS-Cov2 pandemia area, Sylvie Di Filippo, France P-431 Sudden Cardiac Death in RASopathy-associated Hypertrophic Cardiomyopathy: validation of HCM Risk-Kids model and predictors of event, Olga Dimitra Boleti, UK P-429 Pharmacological reduction of oxidative stress counteracts cardiac dysfuction in a murine model of dystrophic cardiomyopathy, Irene Cattapan, Italy P-598 Mid-term results of a nationwide paediatric heart transplantation programme, Karel Koubský, Czech Republic P-595 Mobility and Freedom of Movement: a Novel Out-of-Hospital Treatment for Children with Terminal Cardiac Insufficiency and a Ventricular Assist Device, Kathrin Rottermann, Germany P-630 The Unintended Consequence: Obesity in Children Following a Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy, Alison Howell, Canada P-640 Exercise Capacity, Endothelial Function, Muscle Mass and Strength in Pediatric Fontan Patients, Tania Davila, USA P-652 Cardiopulmonary screening after SARS-CoV-2 infection in children and adolescents returning to sports: a retrospective analysis, Maximilian Dettenhofer, Germany P-585 Cor triatriatum sinistrum in an adolescent presenting as fulminant cardiogenic shock and resuscitated with extracorporeal membrane oxygenation (ECMO), Swathy Subhash, UK P-021 Shared Decision-Making in Decisionally-Impaired Adults. Considerations for the Congenital Heart Provider, David Fernandez, Canada P-003 Factors that may influence symptoms during pregnancy in women with congenital heart disease - data from the Swedish birth registry, Malin Berghammer, Sweden |
| 20:00 | MEETING NETWORKING DINNER (optional ticket event, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | Anticoagulation in Pediatric Cardiology Separate / WG: Task Force on Clinical Drug Trials Chair: Michal Odermarsky, Sweden Co- chair: Wim Helbing, The Netherlands New drugs for anticoagulation in children, Christoph Male, Austria Anticoagulation in general Pediatric Cardiology, Damien Bonnet, France Anticoagulation for valves, shunts and conduits, Thierry Bové, Belgium Anticoagulation during and post catheter interventions, Nikolaus Haas, Germany |
| 10:30 - 11:30 | BREAK |
| 11:30 - 13:00 | AS08 - Pulmonary hypertension, heart failure and transplantation Chairs: Colin Mcmahon & Barbara Pinho Cardoso O-63 Remote Ischaemic Preconditioning in Paediatric Cancer Patients Receiving Anthracycline Therapy: A Double-Blinded Randomized Trial, Y F Cheung, Hong Kong O-64 The utility of speckle tracking imaging to predict short and mid-term outcomes after reverse Potts shunt in patients with Idiopathic PAH, Shatabdi Giri, India O-65 O-65 Rejection surveillance with cell-free DNA using droplet digital PCR: a Swedish national study, Jens Böhmer, Sweden O-66 Survival of children and adolescents with pulmonary arterial hypertension. Data from the BNP-PL registry – PAH children, Joanna Kwiatkowska, Poland O-67 Risk factors for pulmonary hypertension in preterm infants with bronchopulmonary dysplasia, Anne C Kesting, Germany O-68 Immunological Risks for Post-Transplant Lymphoproliferative Disease: The Immunology of Thymectomy and Childhood Cardiac Transplant (ITHACA) study, Ugonna T Offor, UK O-69 Pharmacokinetics and safety of selexipag in children with pulmonary arterial hypertension: A prospective open-label, single-arm, ongoing Phase 2 study, Maurice Beghetti, Switzerland O-70 Pediatric heart transplantation in Spain after circulatory determination of death and in situ normothermic regional perfusion, Luis Garcia Guereta, Spain |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 13:20 - 14:30 | PULMONARY ATRESIA INTACT VENTRICULAR SEPTUM (PA/IVS) Junior Session Chair: Enrico Piccinelli, Italy Co-Chair: Andreas Tulzer, Austria Embryology and morphology of PA/IVS, Agnieszka Grzyb, Poland Multimodality imaging in PA/IVS: One an half ventricle vs biventricular repair, Skaiste Sendzikaite, Lithuania Interventional option in PA/IVS and the fate of ASD at follow-up, Domenico Sirico, Italy Rhythm disturbances in PA/IVS, Guilherme Lourenco, Portugal |
| 14:30 - 16:00 | ECG Quiz Separate / WG: Cardiac dysrhythmias and electrophysiology Chair: Juha-Matti Happonen, Finland Co- chair: Joachim Hebe, Germany |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | AS09 - Adult Congenital Heart Disease O-71 Gut dysbiosis in patients with Fontan circulation, Hideo Ohuchi, Japan O-72 LIVER LIFE - Liver Stiffness affected threw food Intake by Fontan-Patients, teens and adults, determined with Elastography, Richard Mühlberg, Germany O-73 Should Veno-venous Collaterals be closed in Fontan patients?, Shin Ono, Japan O-74 Development and validation of a deep learning algorithm for cardiac MR image quantification in patients with tetralogy of Fallot, Alexander Van De Bruaene, Belgium O-75 Percutaneous edge-to-edge tricuspid repair in patients with systemic right ventricle: A French multicenter cohort study, Xavier Iriart, France O-76 Prognostic value of blood biomarker - hs-TnT, NT-proBNP and CRP - for event free survival in adults with congenital heart disease, Laura Willinger, Germany O-77 Outcomes and pronostic factors of congenitally corrected transposition of great vessels in children, Sylvie Di Filippo, France O-78 The risk of premature atherosclerosis in survivors of childhood cancer: a nested case-control study from the PCS2 cohort, Jonathan P Wong, Canada |
| 20:00 | MEETING NETWORKING DINNER (optional ticket event, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:30 - 10:30 |
Canadian Society Joint Session Lifespan perspective on Congenital Heart Disease- current research, TBA |
| 10:30 - 11:30 | BREAK |
| 11:30 - 13:00 |
MP03 Chairs: Lynda Shaughnessy & Sally Ann Clur P-280 First trimester fetal arrhythimas, Agata Michalczyk, Poland P-296 Maternal Hyperoxygenation Test to Predict Postnatal Urgent Interventions, Maria C Escobar Díaz, Spain P-299 Anusual fetal case of suspected PAPVD with LPA sling – added value of fetal cardiac MRI, Mari Nieves Velasco Forte, UK P-312 Early fetal cardiovascular adaptation to an artificial placenta in a sheep model. Initial approach to extrauterine support for extreme prematurity, Paula C Randanne, Spain P-331 Association of Sex and Age with Presentation and Outcomes of Kawasaki Disease Versus Multisystem Inflammatory Syndrome in Children, Nagib Dahdah, Canada P-395 Current Clinical Profile of Acute Rheumatic fever and Rheumatic Recurrence in Pakistan, Noor Masood Sadiq, Pakistan P-400 Experimental Model of Cardiopulmonary Bypass and Cardiac Arrest in Neonatal Piglets, Madeleine Ball, Spain P-524 Maternal Sensitivity Modulates Child’s Parasympathetic Mode and Buffers Sympathetic Activity in a Free Play Situation, Franziska Köhler Dauner, Germany P-555 The psychological impact of the diagnostic pathway for inherited cardiac conditions in children and adolescents: a systematic review of the literature, Amanda Potterton, UK P-556 What adolescents with congenital heart disease want to know about their heart disease and health including sexual health and contraception, Åsa Burström, Sweden P-547 Impact of a child with congenital heart defect on mother’s quality of life – is there any improvement after surgical correction of the heart defect?, Lacramioara Eliza Chiperi, Romania P-275 Evaluation of a national virtual heart camp using novel educational strategies for children with a Fontan circulation, Carolina Andrea Escudero, Canada P-274 Leveraging technology for the assessment and monitoring of fragile infants with complex congenital heart disease in the community, Kerry Louise Gaskin, UK P-524 Profiles of EEG background and discharge abnormalities in children undergoing cardiac surgery, Jia Li, China |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 14:30 - 16:00 | Building Networks and Cardiac Centres of Excellence Chairs: Jeffrey Jacobs & Colin McMahon Lessons Learned Over An Academic Career, Andrew Redington The All Island CHD Network - a model for collaboration between different countries, Frank Casey, Northern Ireland Building a Centre of Academic Excellence, Daniel Penny, USA Building Excellence With Limited Resources: the Amrita Institute in Kerala Experience, K. Krishna Kumar, India |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | Fetal LQTS Separate / WG: Fetal Cardiology Chair: Wayne Tworetzky, USA Co-chair: Alexander Kovacevic Diagnosis of fetal brady arrhythmia AV-block vs LQTS vs other, Ulrike Herberg, Germany Diagnosis and management of fetal LQT syndrome, Sally-Ann Clur, UK Diagnosis of brady fetal arrhythmias with magnetocardiography, Annette Wacker-Gussmann, Germany Genetics/family screening – Prenatal vs neonatal, Tessa Homfrey,UK |
| 20:00 | MEETING NETWORKING DINNER (optional ticket event, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:30 - 10:30 | Social media – impact on care within congenital heart disease Separate / WG: NURSING AND ALLIED HEALTH PROFESSIONALS Chair: Lynda Shaughnessy, UK Co- chair: Helene Murchan, Ireland Social media and its impact on care – from the health care providers perspective, Jemma Blake & Helen Walker, UK Social media and its impact on care – from the patient/parent/family’s perspective, Jan Lane Martin & Linzi Graham, Ireland Peers support in youth with congenital heart disease using social media/eHealth, Edward Callus, Italy Experiences of congenital heart disease and treatment - what have we learned from patients and parents using online discussion forums?, Jo Wray, UK |
| 10:30 - 11:30 | BREAK |
| 11:30 - 13:00 |
Florence Nightingale Lecture Nursing Research Journey: Brain Structure and Function in Adolescents with Fontan Circulation Chair: Eva Goossens, Belgium |
| 13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
| 14:30 - 16:00 |
Advanced Care Planning and Palliative Care |
| 16:00 - 16:30 | BREAK |
| 16:30 - 18:00 | AS10 - Cardiovascular Morphology Chairs: Matthias Sigler & Agnieszka Grzyb O-79 A Loss-of-Function Variant in INVS in Hypoplastic Left Heart Syndrome, Maarab Mohammed Al Korashy, Saudi Arabia O-80 Virtual reality volume rendering in assessment of ductus arteriosus anatomy in duct-dependent pulmonary circulation, Nikola Topuzov, Poland O-81 Creation of a Neonatal Congenital Heart Digital Twin to Assist with Parent Recognition of Cardiac Compromise following Congenital Heart Surgery, Michael E Kim, USA O-82 Exploring the Gut Microbiota of Infants with Complex Congenital Heart Disease Undergoing Cardiopulmonary Bypass (the GuMiBear study), Claire Magnier, Ireland O-83 Cardiac Rhabdomyomas Presenting With Critical Cardiac Obstruction In Neonates And Infants, Li Yen Ng, Ireland O-84 Trying to define ascending aorta dilatation in paediatric patients with bicuspid aortic valve. Comparison of known nomograms and biometric parameters, Andrea Freixa Benavente, Spain O-85 The cardiovascular phenotype of teenagers after preterm birth, Thomas Salaets, Belgium O-86 Hypoplastic left heart syndrome: experience in our center after the implementation of a multidisciplinary care program, Maria Clara Escobar Diaz, Spain |
| 20:00 | MEETING NETWORKING DINNER (optional ticket event, to be held in an offsite venue) |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | Borderline Left Heart: An unanswered conundrum Seperate / WG: Congenital Heart Surgery Chair: Robert Cesnjevar, Switzerland Co- chair: George Sarris, Greece Borderline Left Heart: Definition, Massimo Cantinotti, Italy Prenatal and Early Postnatal Management, Brian Grant, Northern Ireland Biventricular versus Univentricular repair, Jose Fragata, Portugal Surgical options: Biventricular repair, Mark Redmond, Ireland Innovative management of borderline ventricles, Wayne Tworetsky, USA |
| 10:30 - 11:00 | BREAK |
| 11:00 - 12:30 |
Successes and Failures in the cathlab Chair: Sir Shakeel Qureshi, UK |
| 12:30 - 13:30 |
KEYNOTE LECTURE & AWARD & CLOSING Ageing with Fetal Cardiology Gurleen Sharland, UK |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | Optimising donor and recipient for heart transplant Separate / WG: Pulmonary hypertension, heart failure and transplantation Chair: Zdenka Reinhardt, UK Co- chair: TBA Optimising cardiac transplant recipient status, Zdenka Reinhardt, UK LA Decompression and intervention on ECMO, David Crossland, UK Arrhythmias and Heart failure cause or effect / management, Mark Walsh, Ireland How to evaluate contraindications for heart transplantation? What degree of neurocognitive impairment is acceptable, Jane Cassidy, UK |
| 10:30 - 11:00 | BREAK |
| 11:00 - 12:30 | Advanced hemodynamic analysis by 4D Flow MRI Joint / WG: Cardiac Imaging & Society of Cardiovascular Magnetic Resonance, Pediatric and Congengital Heart Disease Section Chair: Emanuela Valsangiacomo Buechel, Switzerland Co- chair: Heiner Latus, Germany 4D flow consensus update: what's new, Malenka Bissell, UK 4D flow post processing: towards harmonization?, Lamia Ait-Ali, Italy 4D flow novel sequence design for clinical use, Pim van Ooij, The Netherlands 4D MRI for Fetal Imaging, Kuberan Pushparajah, UK |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | Morphological Session: Double outlet ventricles Separate / WG: Cardiovascular Morphology Chair: Monique Jongbloed, Netherlands Co- chair: Matthias Sigler, Germany The anatomy of double outlet ventricles, Loucile Houyel, France 3D modelling and 3D printing of double outlet ventricles, Adam Kolesnik, Poland Surgical perspective of double outlet aspects, Bart Meyns, Belgium |
| 10:30 - 11:00 | BREAK |
| 11:00 - 12:30 | Heart failure in adult congenital heart disease: an update Separate / WG: Adult Congenital Heart Disease Chair: Margerita Brida, Croatia Co- chair: Werner Budts, Belgium Right ventricular fibrosis, where does it come from and what does it mean?, Paolo Ferrero, Italy The failing univentricle, how to deal with it?, Louise Coats, UK Biomarkers in adult congenital heart disease, how to interpret?, Robert Kauling, Netherlands Genetics and heart failure in adult congenital heart disease: is there a connection?, Julie De Backer, Belgium |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | Cardiac MR as a clinical and clinical trial tool: Basics of MR imaging and CMR outcome markers in clinical trials in congenital heart disease Joint / WG: Cardiac Imaging & Task Force on Clinical Drug Trials Chair: Heynric Grotenhuis, Netherlands Co- chair: Daniel de Wolf, Belgium Basics of MRI everyone should know, Gerald Greil, USA Clinical MRI evaluation of the Fallot patient and MR outcome markers for clinical trials, Sylvia Krupickova, UK Clinical MRI evaluation of single ventricle patients and MR outcome markers for clinical trials, Arno Roest, The Netherlands Combining MRI and biomarkers to prognosticate risk in CHD, Wim Helbing, The Netherlands |
| 10:30 - 11:00 | BREAK |
| 11:00 - 12:30 |
Newer Echocardiographic Techniques for Assessment of Congenital Heart Disease |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | Physical activity and the impact on wellbeing of CHD patients Joint / WG: Neurodevelopment and Psychosocial Care & Nurses and Allied Health Professionals & Sports cardiology, physical activity, prevention group Chair: Kristof Vandekerckhove, Belgium Co- chair: Lynda Shayghnessy, UK Physical exercise and neurocognitive training on neuropsychological and QoL outcomes in CHD, Johanna Calderon, France How to stimulate children and especially their parents to participate in sport? Designing an exercise and activity intervention program for children with CHD, Frank Casey, Northern Ireland How do we advise on participation in competitive sport in children with CHD, Jan Sunnegardh, Sweden A National Comparative Investigation of Twins With Congenital Heart Defects for Neurodevelopmental Outcomes and Quality of Life (Same Same, but Different?), Julia Remmele, Germany |
| 10:30 - 11:00 | BREAK |
| 11:00 - 12:30 | The latest knowledge in Pulmonary Hypertension Separate / WG: Pulmonary hypertension, heart failure and transplantation Chair: Hannes Sallmon, Germany Co- chair: Dimpna Calila Albert Brotons, Saudi Arabia Update on genetic aetiologies of pulmonary hypertension, Rolf Berger, The Netherlands Update on pulmonary hypertension related to PVOD, Karin Tran Lundmark, Sweden Imaging to stratify and monitor pulmonary hypertension, Hakan Wahlander, Sweden Timing and selection of reverse Potts shunt for PAH, Maurice Beghetti, Switzerland |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | AS11 - Sports Cardiology, Physical Activity and Prevention Chairs: Doris Ehringer & TBA O-87 Exercise capacity remains stable in Fontan patients entering adulthood, Maren Emilie Hebeltoft Ravnda, , Denmark O-88 Leg-focused high-weight resistance training in children with a Fontan circulation, Linda Elisabeth Scheffers, Netherlands O-89 Energy Drinks: Do They Give the Pediatric Cardiovascular System Wings? - Results of the EDUCATE-Study, Felix Sebastian Oberhoffer, Germany O-90 Early life predictors for blood pressure in healthy adolescents are not associated with enhanced carotid intima-media thickness (cIMT), Isabelle Adrienne Van Der Linden, Netherlands O-91 Cutaneous Microcirculation in patients with congenital heart disease or Marfan syndrome, Constance Weismann, Germany O-92 Stairway to heaven - Evaluation of cardiorespiratory fitness with a simple standardized stair climbing test incomparison to standard cardiopulmonary, Simone Katrin Dold, Germany O-93 Aerobic fitness change with time in children with congenital heart disease: A controlled cohort study, Pascal Amedro, France O-94 Anti-Coagulation with Warfarin for Paediatric Cardiac Indications: A National Review, Stephen T. O’brien, Ireland |
| 10:30 - 11:00 | BREAK |
| 11:00 - 12:30 | Challenges in hypoplastic left heart syndrome Separate / WG: Paediatric Cardiovascular Intensive Care Chair: Joan Sanchez di Toledo, Spain Co- chair: Ricardo Munoz, USA Co-chair: Nicole Sekarski, Switzerland HLHS preoperative management (hypoxic mixture, ventilation, nutrition), Joan Sanchez di Toledo, Spain HLHS intervention: Norwood – BTS, Norwood Sano, hybrid, delayed Norwood, Stefano Di Bernardo, Switzerland HLHS postoperative management particularly inotropes and sedation, Ricardo Munoz, USA |
| Time Slot | |
| 08:00 - 09:00 | BUSINESS MEETING |
| 09:00 - 10:30 | AS12 - Paediatric Cardiovascular Intensive Care Chairs: Dimpna Calila Albert Brotons & Damien Schaffner O-95 Predicting cardiogenic shock in multisystem inflammatory syndrome in children, Saïd Bichali, France O-96 Prevalence and Patterns of Antibiotic Treatment in Neonates with Critical Congenital Heart Defects, Jessica A. Davis, USA O-97 Clinical Profile and Pre-operative Critical Care Needs of Children with TAPVC: A Retrospective Study from a Pediatric Cardiac Critical Care Unit, Arun Kumar Baranwal, India O-98 Left atrial strain and duration of intensive care in children with congenital diaphragmatic hernia, Katarina Övermo Tydén, Sweden O-99 Cardiac dysfunction requiring intensive care management in PIMS-TS and Covid 19 infection; Ireland’s experience through the pandemic, Nicola Mccay, Ireland O-100 Thrombogenic myocardial infarction in newborn, Franziska Markel, Germany O-101 Clinical features and echocardiography of Multisystem Inflammatory Syndrome in children in the Republic of Ireland, April 2020 to October 2022., Bryony Treston, Ireland O-102 Aspirin resistance in a cohort of paediatric patients with in-situ bio-prosthetic heart valves, Sean T Kelleher, Ireland |
| 10:30 - 11:00 | BREAK |
| 11:00 - 12:30 | Models of care in nursing within congenital heart disease Separate / WG: NURSING AND ALLIED HEALTH PROFESSIONALS Chair: Gaby Stoffel, Switzerland Co- chair: Jennie Ryan, Ireland New innovations in clinical practice (virtual outpatient clinics) - Niamh Maguire, Ireland Person centred care, child centred care, family centred care – same or different, Imelda Coyne, Dublin Patient monitoring and education over a tailored digital platform- Heba Nashat, UK Perioperative creative music therapy with critically ill infants and their parents-a mixed methods case-study- Rahel Gotsmann, Switzerland |
Don't miss a thing! Subscribe to our newsletters and be the first to know.